Ask The Recruiter
Adapt my resume

ImmunoBiota Therapeutics

Funding reported, Seed, last update 1 day ago

Pharma biotech · Headquarters Melbourne, Australia

Everything we hold on ImmunoBiota Therapeutics, newest first. Every line links to the filing or report it came from.

1 update tracked
$5M disclosed funding
4 Sep 2026 tracked since
Melbourne, Australia where

This profile is thin because we hold one source document on ImmunoBiota Therapeutics so far, not because nothing else has happened there. We only publish what we have read on a primary source and can link to. So a profile fills up as filings and reports come in, and we never seed it from an estimate. We keep profiles at this stage out of our sitemap and mark them noindex until they carry enough to be worth a search result of their own.

  1. 2026-09-04
    Headcount Not Stated Growing and expanding

    Melbourne biotech ImmunoBiota progresses $5m seed raise for world-first oral Type 1 diabetes therapy

    ImmunoBiota has $5M of new capital in Melbourne for its Type 1 diabetes therapy. The announcement does not disclose hiring plans; watch its careers page for research and clinical healthcare roles.

    Melbourne, Australia · $5M raised · News Report · Business News Australia · No archive snapshot yet. We re-check weekly; next check by Sep 12.

Cite this pageImmunoBiota Therapeutics. Talent Intelligence Tracker, AskTheRecruiter.com. Accessed Sep 5, 2026. https://asktherecruiter.com/blog/talent-intelligence-tracker/company/immunobiota-therapeutics/ Licensed CC BY 4.0; every record links to the document behind it.

The read-through on each line is our interpretation. The headline and figures come from the linked source. Data licensed CC BY 4.0. Back to the tracker